Cargando…
Modelling the impact of a new tobacco product: review of Philip Morris International’s Population Health Impact Model as applied to the IQOS heated tobacco product
OBJECTIVES: We review the Population Health Impact Model (PHIM) developed by Philip Morris International and used in its application to the US Food and Drug Administration (FDA) to market its heated tobacco product (HTP), IQOS, as a modified-risk tobacco product (MRTP). We assess the model against F...
Autores principales: | Max, Wendy B, Sung, Hai-Yen, Lightwood, James, Wang, Yingning, Yao, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240026/ https://www.ncbi.nlm.nih.gov/pubmed/30275170 http://dx.doi.org/10.1136/tobaccocontrol-2018-054572 |
Ejemplares similares
-
IQOS debut in the USA: Philip Morris International’s heated tobacco device introduced in Atlanta, Georgia
por: Churchill, Victoria, et al.
Publicado: (2020) -
IQOS: examination of Philip Morris International’s claim of reduced exposure
por: St.Helen, Gideon, et al.
Publicado: (2018) -
Heated tobacco products: the example of IQOS
por: Glantz, Stanton A
Publicado: (2018) -
Tobacco-specific nitrosamines (TSNA) in heated tobacco product IQOS
por: Leigh, Noel J, et al.
Publicado: (2018) -
Household Surveys in the General Population and Web-Based Surveys in IQOS Users Registered at the Philip Morris International IQOS User Database: Protocols on the Use of Tobacco- and Nicotine-Containing Products in Germany, Italy, and the United Kingdom (Greater London), 2018-2020
por: Sponsiello-Wang, Zheng, et al.
Publicado: (2019)